DJS Antibodies
Pre-clinicalA UK-based biotech company developing antibody therapeutics targeting difficult-to-drug membrane proteins.
Founded
2017
Focus
AntibodiesBiologics
About
A UK-based biotech company developing antibody therapeutics targeting difficult-to-drug membrane proteins.
Funding History
3Total raised: $57.5M
Series B$40MNovo HoldingsOct 15, 2022
Series A$15MSR OneSep 15, 2020
Seed$2.5MUndisclosedJun 15, 2018
Company Info
TypePrivate
Founded2017
LocationOxford, United Kingdom
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile